C

CANbridge Life Sciences Ltd.

26 employees

CANbridge Pharmaceuticals is a bio-pharmaceutical company accelerating development and commercialization of specialty healthcare .

Basic info

Industry

pharmaceuticals

Sectors

Biotechnology

Health Care

Pharmaceutical

Date founded

2012

Funding rounds raised

Total raised

$98M

from 19 investors over 19 rounds

C

CANbridge Life Sciences Ltd. raised $43M on December 1, 2020

Investors: LYFE Capital, Summer Capital, Hudson Bay Capital Management LP, Casdin Capital, LLC, RA Capital Management, L.P. and Bulldog Innovation Group

C

CANbridge Life Sciences Ltd. raised $98M on February 18, 2020

Investors: Yuanming Capital, General Atlantic, WuXi AppTec, Tigermed, Hudson Bay Capital Management LP and RA Capital Management, L.P.

C

CANbridge Life Sciences Ltd. raised $38M on August 1, 2018

Investors: Qiming Venture Partners

C

CANbridge Life Sciences Ltd. raised $25M on May 23, 2017

Investors: Yuanming Capital, WuXi AppTec and Qiming Venture Partners

C

CANbridge Life Sciences Ltd. raised $10M on October 27, 2015

Investors: Qiming Venture Partners

C

CANbridge Life Sciences Ltd. raised $10M on December 2, 2014

Investors: 泰福资本 TF Capital and Qiming Venture Partners